Skip to main content
AIM Vaccine Co., Ltd. logo

AIM Vaccine Co., Ltd. — Investor Relations & Filings

Ticker · 6660 ISIN · CNE100005KF2 HKEX Manufacturing
Open in API
Filings indexed 232 across all filing types
Latest filing 2026-05-21 Proxy Solicitation & In…
Country HK Hong Kong
Listing HKEX 6660

About AIM Vaccine Co., Ltd.

https://www.aimbio.com

AIM Vaccine Co., Ltd. is a biopharmaceutical company focused on the research, development, manufacturing, and commercialization of vaccines for human use. The company's mission is to produce high-quality vaccines to safeguard global health. It holds a leading position among privately-owned vaccine enterprises in its primary market. The core product portfolio includes established vaccines such as Recombinant Hepatitis B Vaccine (Hansenula polymorpha), Inactivated Hepatitis A Vaccine (Human Diploid Cell), and Meningococcal Polysaccharide Vaccine. AIM Vaccine is also a major global supplier of rabies vaccines, committed to leading technological advancements in this area. The company actively expands its pipeline, which features advanced candidates like the 13-valent pneumonia conjugate vaccine and iterative serum-free rabies vaccine, alongside strategic investments in mRNA technology, including an mRNA COVID-19 vaccine candidate.

Recent filings

Filing Released Lang Actions
FORM OF PROXY OF HOLDERS OF H SHARES FOR USE AT THE 2026 FIRST EXTRAORDINARY GENERAL MEETING TO BE HELD ON JUNE 10, 2026
Proxy Solicitation & Information Statement Classification · 91% confidence The document is a form of proxy for H-share holders to vote at the 2026 first Extraordinary General Meeting. It is a solicitation of voting instructions and proxy appointment, which falls under Proxy Solicitation & Information Statement (PSI), rather than the meeting results or report itself.
2026-05-21 English
NOTICE OF THE 2026 FIRST EXTRAORDINARY GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 85% confidence The document is a formal notice of an Extraordinary General Meeting (EGM) of AIM Vaccine Co., Ltd. dated May 21, 2026, detailing the meeting date/time/venue, special and ordinary resolutions to be considered, proxy appointment procedures, record dates, and other shareholder meeting logistics. It contains no financial statements or audit data, nor does it report voting outcomes. Instead, it provides information to shareholders and solicits their attendance and proxy voting at the meeting. This matches the definition of a Proxy Solicitation & Information Statement (PSI).
2026-05-21 English
PROPOSED APPLICATION BY THE COMPANY FOR THE A SHARE LISTING ON THE BEIJING STOCK EXCHANGE AND ISSUANCE OF DOMESTIC SHARES UNDER SPECIFIC MANDATE
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a circular to shareholders containing a "Letter from the Board," definitions, proposed resolutions, amended articles and rules, and a notice of a 2026 Extraordinary General Meeting along with a proxy form. It is clearly a proxy solicitation/information statement sent to shareholders to vote at the EGM. It does not contain actual financial statements or earnings data, nor is it simply announcing a report publication. Therefore, it is best classified under Proxy Solicitation & Information Statement.
2026-05-21 English
FORM OF PROXY OF HOLDERS OF H SHARES FOR USE AT THE ANNUAL GENERAL MEETING TO BE HELD ON JUNE 10, 2026
Proxy Solicitation & Information Statement Classification · 85% confidence The document is a Form of Proxy for holders of H shares to vote at the Annual General Meeting on June 10, 2026. It solicits shareholder voting instructions and provides proxy appointment details. This falls under materials sent to shareholders to request votes for a meeting, matching the Proxy Solicitation & Information Statement category (PSI).
2026-05-18 English
NOTICE OF 2025 ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 88% confidence The document is a formal notice of the 2025 Annual General Meeting, detailing resolutions to be voted on, proxy appointment procedures, meeting logistics, and referring shareholders to the Circular for further details. This is a solicitation of votes and provision of information for the upcoming meeting, which matches the definition of a Proxy Solicitation & Information Statement (Code: PSI), rather than materials presented during the AGM or the AGM proceedings themselves.
2026-05-18 English
(1) RESIGNATION OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND PROPOSED ELECTION OF DIRECTORS; AND (2) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION AND RULES OF PROCEDURES OF THE BOARD OF DIRECTORS
Board/Management Information Classification · 90% confidence The document is an announcement under Rule 13.51(1) of the HK Listing Rules describing the resignation of an independent non‐executive director, the nomination of new directors, and proposed amendments to the company’s articles of association and board procedures. It clearly relates to changes in the composition and governance structure of the board, fitting the Board/Management Information category.
2026-05-18 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.